BioSpace News Archive

Heat Biologics, Inc. announces it has commenced development of a new biosecurity/biodefense initiative.

Enveric Biosciences today is issuing an open letter to shareholders.

Fist Assist Devices, LLC, announces that data associated with the p-FACT cohort, a data subset of the recently completed shows clear evidence that the Fist Assist device dilates the perforator vein.

AmerisourceBergen announced the appointment of Elizabeth Campbell as Executive Vice President and Chief Legal Officer.

Castor announced that it is powering the next generation of clinical trials with more than 30 digital therapeutics (DTx) studies ongoing.

Cortexyme, Inc. will participate as a featured speaker covering its pivotal Phase 2/3 GAIN Trial

The United States Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed ’s (NASDAQ: ABMD) Impella ECP expandable percutaneous heart pump.

Natus Medical Incorporated, a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced the appointments of Bryant M. Moore, Ph.D. and Eric J. Guerin to the Company’s Board of Directors.

The US Food and Drug Administration has approved the first-ever pharmaceutical treatment for patients with von Hippel-Lindau disease, a genetic condition putting patients at risk of developing several cancers and other types of tumors.

Cerebras Systems, the pioneer in high performance artificial intelligence (AI) compute, and Peptilogics, a biotechnology platform company and an emerging leader in leveraging computation to design novel therapeutics, today announced a collaboration to accelerate the development cycle of peptide therapeutics through AI.